Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolai Juul Birkbak

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Scientific Reports|December 4, 2013
Computational optimisation of targeted DNA sequencing for cancer detectionPierre Martinez, Nicholas McGranahan, Nicolai Juul Birkbak, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2024
Exploring the impact of body mass index on tumor biology and cancer developmentJohanne Ahrenfeldt, Stine Carstensen, Ida Maria Hemdorff Eriksen, et al.
Science Translational Medicine|April 17, 2015
Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionNicholas McGranahan, Francesco Favero, Elza C de Bruin, et al.
Nature|November 29, 2013
Inconsistency in large pharmacogenomic studiesBenjamin Haibe-Kains, Nehme El-Hachem, Nicolai Juul Birkbak, et al.
Cancers|July 27, 2022
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in MelanomaJesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, et al.
Plos One|December 17, 2020
Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectumSigrid Salling Árnadóttir, Trine Block Mattesen, Søren Vang, et al.
The Journal of Pathology|May 30, 2013
Parallel evolution of tumour subclones mimics diversity between tumoursPierre Martinez, Nicolai Juul Birkbak, Marco Gerlinger, et al.
F1000Research|July 14, 2016
Assessment of pharmacogenomic agreementZhaleh Safikhani, Nehme El-Hachem, Rene Quevedo, et al.
Melanoma Research|June 9, 2023
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panelJudit Kisistók, Ditte Sigaard Christensen, Mads Heilskov Rasmussen, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Scientific Reports|December 4, 2013
Computational optimisation of targeted DNA sequencing for cancer detectionPierre Martinez, Nicholas McGranahan, Nicolai Juul Birkbak, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2024
Exploring the impact of body mass index on tumor biology and cancer developmentJohanne Ahrenfeldt, Stine Carstensen, Ida Maria Hemdorff Eriksen, et al.
Science Translational Medicine|April 17, 2015
Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionNicholas McGranahan, Francesco Favero, Elza C de Bruin, et al.
Nature|November 29, 2013
Inconsistency in large pharmacogenomic studiesBenjamin Haibe-Kains, Nehme El-Hachem, Nicolai Juul Birkbak, et al.
Cancers|July 27, 2022
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in MelanomaJesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, et al.
Plos One|December 17, 2020
Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectumSigrid Salling Árnadóttir, Trine Block Mattesen, Søren Vang, et al.
The Journal of Pathology|May 30, 2013
Parallel evolution of tumour subclones mimics diversity between tumoursPierre Martinez, Nicolai Juul Birkbak, Marco Gerlinger, et al.
F1000Research|July 14, 2016
Assessment of pharmacogenomic agreementZhaleh Safikhani, Nehme El-Hachem, Rene Quevedo, et al.
Melanoma Research|June 9, 2023
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panelJudit Kisistók, Ditte Sigaard Christensen, Mads Heilskov Rasmussen, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Pageof 2